ArticleBreast cancer research and treatment2024

National trends in neoadjuvant chemotherapy utilization in patients with early-stage node-negative triple-negative breast cancer: the impact of the CREATE-X trial.

Christine Rogers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.